36 min listen
EUVC #280: Tej Panesar, Partner at Prism Ventures on LP investing in life sciences
FromEUVC
ratings:
Length:
76 minutes
Released:
Feb 15, 2024
Format:
Podcast episode
Description
Today, we are joined by Tej Panesar. Tej is a Partner at Prism Ventures, the UK-based institutional investor focused on the life sciences and healthcare sectors.Prism invests in the best-of-breed funds managed in the US, UK, and Europe through fund of funds and co-investment programs. He previously worked as an Investment Director at British Patient Capital, a UK government-backed institution very similar to the EIF and one of the largest investors in UK venture capital.With +425M pounds invested in the UK and Europe, Tej led investments into famed firms like IQ Capital and SV Health. Tej and his team have a wide lens across the life sciences and healthcare industries but a strong focus on traditional biopharma and areas like tech bio.Go to eu.vc for our core learnings and the full video interview ?Chapters:00:00:00 - Introduction about Prism Ventures00:03:55 - From Crowdfund Platforms to Venture Capital00:11:09 - LP Perspective on High-Tech Work00:14:50 - The Non-Binary Nature of the Life Sciences Sector00:18:34 - The Exciting Opportunities in Biotechnology and Healthcare00:26:28 - Adoption Challenges in the Health Sector00:30:23 - The Value Equation of Learning Technologies00:34:01 - Symbiotic Approaches in Life Sciences00:37:50 - Focus on Life Science and Healthcare00:41:36 - Investing in Europe vs the US00:45:18 - Portfolio Construction and Diversification00:49:18 - Building a Long-Term Institution00:53:04 - Diversity and Culture in VC Firms00:56:50 - Evaluating Team Culture and Portfolio Construction01:00:29 - The Importance of a Viable Business Plan01:04:04 - Scaling the Fund Size01:07:48 - Investing as a Team
Released:
Feb 15, 2024
Format:
Podcast episode
Titles in the series (100)
#1 Marc Lohrmann, Vesalius Biocapital: Episode 1 features Marc Lohrmann, Managing Partner of Vesalius Biocapital III, a 120 €M venture capital fund investing in late-stage companies in drug development, medical devices & diagnostics and eHealth / mHealth, across all of Europe. Prior to... by EUVC